Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment

NCT01414075 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Dialysis
Anemia

Interventions

DRUG: Roxadustat
DRUG: Oral Iron
DRUG: IV Iron

Sponsor

Kyntra Bio

Collaborators

[object Object]